Swartz, A., Congdon, K., Nair, S., Li, Q.-J., Herndon, J., Suryadevara, C., … Sampson, J. (2021). CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY. In NEURO-ONCOLOGY (Vol. 23, pp. 218–218).

Swartz, Adam, Kendra Congdon, Smita Nair, Qi-Jing Li, James Herndon, Carter Suryadevara, Katherine Riccione, et al. “CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY.” In NEURO-ONCOLOGY, 23:218–218, 2021.

Swartz A, Congdon K, Nair S, Li Q-J, Herndon J, Suryadevara C, et al. CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY. In: NEURO-ONCOLOGY. 2021. p. 218–218.

Swartz, Adam, et al. “CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY.” NEURO-ONCOLOGY, vol. 23, 2021, pp. 218–218.

Swartz A, Congdon K, Nair S, Li Q-J, Herndon J, Suryadevara C, Riccione K, Reedy J, Cook S, Archer G, Norberg P, Sanchez-Perez L, Sampson J. CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY. NEURO-ONCOLOGY. 2021. p. 218–218.